Business · 1 sources covering this

Symbiotec IPO draws positive brokerage views on strong API portfolio growth

Symbiotec Pharmalab IPO is a mix of a fresh issue of ₹15 lakh and an offer for sale of ₹1.63 crore. The price band for the offer is set issue price band at ₹938 to ₹988 per share.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Symbiotec IPO draws positive brokerage views on strong API portfolio growth
Symbiotec Pharmalab IPO is a mix of a fresh issue of ₹15 lakh and an offer for sale of ₹1.63 crore. The price band for the offer is set issue price band at ₹938 to ₹988 per share.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/43d2ee102fda58e1ec5a1a8daff8bd76d84a9378"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Symbiotec IPO draws positive brokerage views on strong API portfolio growth"></iframe>

Symbiotec IPO draws positive brokerage views on strong API portfolio growth

How 1 sources are covering this

Symbiotec IPO draws positive brokerage views on strong API portfolio growth

More from Business

Telangana govt to develop dedicated ride-hailing app for auto drivers'

Sebi rejects settlement applications by 13 foreign funds in Adani probe

Piyush Goyal lands in Japan as India eyes ₹60,000 crore investment boost in 10 years: What's on the agenda?

A plot twist awaits Paramount-Warner Bros merger

Reader

Trust & legal

Across the network